Biotts S.A. and Bioton S.A. have signed a Proof of Concept agreement to test the feasibility of transporting insulin through the skin using the patented MTC-Y carrier. Bioton will supply insulin for patches, which will enable long-lasting drug delivery through the skin using a transdermal system from Biotts. After the PoC phase, the biotech will […]
Read the full article